EvidentIQ, LLC (DBA Fortress Medical Systems)

Fortress Medical Systems, LLC. provides a powerful and integrated solution for clinical trial management through its flagship product, Clindex®. Founded in 1997, the company has been at the forefront of revolutionizing clinical data management and electronic data capture. Acquired by EvidentIQ Group in 2021, Clindex® has expanded its functionality to cater not only to medical device trials but also pharmaceutical, diagnostic, and combination product studies. With a global client base, including Fortune 500 corporations, start-ups, and contract Clinical Research Organizations (CROs), Clindex® has been utilized in numerous studies, notably for FDA marketing applications. The software has demonstrated its scalability and reliability, having been audited by the FDA without any findings or deficiencies attributed to it. The company offers a range of services, from implementation and configuration to full Application Service Provider (ASP) services under a Software as a Service (SaaS) model. Fortress Medical Systems' impressive client retention rate, with over 90% of clients over the past decade still utilizing Clindex®, speaks volumes about the satisfaction and effectiveness of their solutions. The company's influence extends to institutions like the US Centers for Disease Control and Prevention, cementing its position as a trusted player in the industry. For more information, visit www.fortressmedical.com.